October 6, 2023 Innovative Trial Design Approaches to Model Informed Drug Development in Rare and Neurological Diseases Are you passionate about making a difference in the fields of neurology and rare diseases? Do you want to explore new methods that
October 3, 2023 C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research TUCSON, Ariz., October 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Confer
October 2, 2023-October 6, 2023 View Now — European Association of the Study of Diabetes Annual Meeting, C-Path T1D Consortium Presentation and Reception Members of the C-Path team joined EASD 2023 for groundbreaking discussions on Immunotherapy and Beta Cell Preservation in Type 1 D
September 28, 2023-September 29, 2023 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s Predictive Safety Testing Consortium hosted a public workshop on September 28-29, 2023 in Bethesda, Ma
September 25, 2023 Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant.
September 20, 2023 The CPP Consortium Welcomes Biohaven as its Newest Member The Critical Path for Parkinson’s Consortium is excited to welcome Biohaven as its newest member. Biohaven is a biopha
September 19, 2023-September 30, 2023 NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and Innovation The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) workshop highlights secondary use research that utilized
September 18, 2023 C-Path and EATRIS Join Forces with New Collaboration Agreement AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastruct
September 12, 2023 C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development. TUCSON, Ariz., Septe
September 11, 2023-September 13, 2023 View Now: 2023 Rare and Orphan Disease Conference presented by C-Path Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will leave this 2.5
